Real-time enrollment status for this von willebrand disease (vwd) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:45 PM UTC
| NCT Number | NCT07115004 |
| Recruiting Status | Recruiting |
| Condition | Von Willebrand Disease (VWD) |
| Phase | PHASE3 |
| Target Enrollment | 60 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Vega Therapeutics, Inc |
| Last Updated on CT.gov | September 14, 2026 (4 weeks ago) |
As of October 12, 2026: Clinical trial NCT07115004 is currently recruiting participants. This phase3 study for von willebrand disease (vwd) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Vega Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07115004 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07115004 was last updated 4 weeks ago (September 14, 2026). HelloStudys verifies this status automatically.